Cargando…
Glucose-6-phosphate dehydrogenase inhibitor for treatment of severe COVID-19: Polydatin
The COVID-19 pandemic as the largest global public health crisis is now considered as an emergency at the World Health Organization (WHO). As there is no specific therapy for SARS-CoV-2 infection at present and also because of the long time it takes to discover a new drug and the urgent need to resp...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959677/ https://www.ncbi.nlm.nih.gov/pubmed/34024514 http://dx.doi.org/10.1016/j.clnesp.2021.02.021 |